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ABSTRACT The neurotoxins, batrachotoxin and veratridine, are specific activators
of sodium channels and cause an increase in the rate of 22Na uptake in neuroblastoma
cells. Yohimbine, an indolalkylamine alkaloid, inhibits this batrachotoxin-induced
22Na uptake. The dose-response curve of yohimbine suggests that the inhibitor acts
reversibly on a single class of binding sites with dissociation constant of 3-4 x 10-5 M.
The dissociation constant is not affected by depolarization from -41 to 0 mV. Kinetic
and equilibrium experiments indicate that yohimbine is a competitive inhibitor of the
action of batrachotoxin. These results support the conclusion that yohimbine inhibits
the sodium flux by acting on the channel gating mechanism rather than by occluding
the channels.
INTRODUCTION
Yohimbine is an indolealkylamine alkaloid obtained from Corynanthe yohimbe and
plants of the Apocynaceous family. It blocks certain responses of the effect on cells to
epinephrine and sympathetic nerve impulses (Nickerson, 1949); and possesses anti-
serotonin activity on peripheral vascular systems (Papesch et al., 1971). High concen-
trations (1O-3 g/ml) of yohimbine cause conduction blockage upon repetitive stimula-
tion in frog and toad nerves (Shaw et al., 1955). Lipicky et al.,' using voltage clamp
techniques, demonstrated that yohimbine reduces the peak sodium current in squid
giant axons in a use-dependent manner. Specifically, the extent of the inhibition of
sodium current is enhanced by increasing the magnitude of depolarizing pulses and
decreased by hyperpolarizing prepulses. These results are interpreted in terms of a
modified channel-kinetics model.' In that model, it is assumed that yohimbine binds
to the gating molecules of sodium channels, and modifies their opening and closing
rates. One way to test this hypothesis is to determine the interaction of yohimbine with
drugs that are known to bind to the channel gates.
Dr. Catterall's present address is: Department of Pharmacology, University of Washington, Seattle, Wash.
98105.
' Lipicky, R. J., D. L. Gilbert, and G. Ehrenstein. Effect of yohimbine on squid axons. Manuscript sub-
mitted for publication.
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The neurotoxic alkaloids, batrachotoxin (BTX) and veratridine can cause an in-
crease in sodium permeability and depolarization of membrane potential in various
nerve and muscle preparations (Narahashi et al., 1971; Albuquerque et al., 1971;
Ulbricht, 1969) and in cultured neuroblastoma cells (Catterall and Nirenberg, 1973;
Catterall, 1975). Several lines of evidence (considered in the discussion section) suggest
that these toxins increase sodium conductance. In these experiments, we have studied
yohimbine inhibition of sodium channels activated by batrachotoxin and veratridine.
Preliminary results of this work have been reported (Huang et al., 1977).
MATERIALS AND METHODS
Material
Yohimbine was obtained from Aldrich Chemical Co., Inc. (Milwaukee, Wis.); [3H]leucine,
22NaCl were purchased from New England Nuclear (Boston, Mass.). Veratridine was from K
and K Laboratories, Inc., (Plainview, N.Y.). Dulbecco-Vogt modification of Eagle's minimal
medium (DMEM) and Dulbecco's phosphate-buffered saline were prepared by the Media Unit
of NIH. Fetal calf serum was from Grand Island Biological Co. (Grand Island, N.Y.). Re-
crystallized trypsin was obtained from Worthington Biochemical Corp.. (Freehold, N.J.).
Batrachotoxin was kindly supplied by Dr. J. Daly and Dr. B. Witkop of the Laboratory of
Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, NIH. This toxin
is stored in ethanol at 100 times the concentration used in the experiment, and was added to
the assay media immediately before use.
Cell Culture
Cell line N18 of mouse neuroblastoma C 1300 was used in the present work. The cells were
grown as described (Catterall and Nirenberg, 1973). In brief, the cells were propagated in
growth medium consisting of 5% fetal calf serum, 95% DMEM in humidified atmosphere of
10% C02, 90%I air. For experiments, cells were suspended from stock culture with Ca++,
Mg++-free Dulbecco's phosphate-buffered saline and 0.02% (wt/vol) trypsin; and were then
seeded with growth medium at a density of 15,000 cells/cm2 in multi-well plates (16 mm diam-
eter, Costar Co., Mass.). The growth medium was changed on days 3 and 5, and cultures were
ready for use at day 6 or 7. 0.02 MCi/ml [3H]leucine was added with the growth medium at
day 5 so that the protein recovery in the experiments can be measured from 3H counts.
Measurement of22Na Uptake
For determination of the rate of 22Na uptake, the cells are first preincubated with drug and/or
toxin at 36°C for 30 min in a sodium-free medium consisting of 135 mM KCI, 5.5 mM glucose,
0.8 mM MgSO4, and 50 mM Hepes (pH adjusted to 7.4 with Tris). After the cells become
equilibrated with the drug, the rate of 22Na uptake is measured for 30 s or the specified time.
The uptake medium contains 120 mM choline chloride, 10 mM NaCI, 5.0 mM KCI, 5.5 mM
glucose, 0.8 mM MgSO4, 5 mM ouabain, 1.0 uCi/ml 22NaCl. The uptake was terminated by
washing the cells four times with 3 ml of 0C wash medium which is composed of 130 mM cho-
line chloride, 5.0 mM KCl, 1.8 mM CaC12, 0.8 mM MgSO4, 5 mM Hepes (pH = 7.4 adjusted
with Tris). Under these conditions, the membrane potential of the cell is -41 mV during the
22Na+ flux measurement (Catterall, 1977). Since the concentration of Na' is low (10 mM), the
increase in Na+ permeability caused by veratridine and batrachotoxin has no effect on mem-
brane potential. The measurements are therefore made at constant membrane potential. Under
these conditions, the measured 22Na' influx is directly proportional to sodium permeability ac-
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cording to the Goldman-Hodgkin-Katz (1943, 1949) equation. In experiments in which 22Na+
influx was measured in the presence of different concentrations of Na+ and at different mem-
brane potentials, the dependence of measured 22Na+ influx on [Na+ ]I ,, and on membrane
potential conformed to the Goldman-Hodgkin-Katz equation confirming that, under the experi-
mental conditions used, measured 22Na' influx is directly proportional to sodium permeability.
Cells were removed by incubating them in 0.5 ml of 0.4 N NaOH. The suspensions were then
transferred into a series of vials, each containing I ml of I M Tris-HCl (pH = 7.4), and 10 ml
of scintillation mixture (5.53% (vol/vol) RPI scintillator fluid, 61.14% toluene and 33.33%
Triton X-100). The cell protein is determined by a modification of the Lowry method (Lowry
et al., 1951). The uptake is expressed in terms of nanomoles per minute per milligram of protein.
RESULTS
Inhibition by Yohimbine
Batrachotoxin, a toxin produced by the Colombian frog, Phyllobates aurotaenia, in-
creases the rate of 22Na uptake in neuroblastoma cells as much as 25-fold (Catterall,
1975). Since this increase is completely abolished by a low concentration of tetrodo-
toxin (TTX), a specific inhibitor of the sodium channel (Narahashi et al., 1964, Kao,
1966), and is only observable with electrically excitable cells (Catterall and Nirenberg,
1973); the increase in 22Na+ uptake is due to activation of sodium channels. The ac-
tivation of 22Na+ uptake reaches half-maximum at 0.4 AM BTX. Most experiments,
unless indicated, are performed by using I ,uM BTX, which corresponds to 90% of the
maximum response. This concentration is chosen for the present work because of the
low solubility of BTX in water and limited supply of the toxin.
We have found that yohimbine blocks the sodium channels in cultured neuro-
blastoma cells. Specifically, yohimbine inhibits 95% of BTX-dependent activated 22Na
uptake at 4 mM concentration (Fig. I a). This is better illustrated on a semilog plot of
the same data vs. time (Fig. I b). This plot yields a straight line with the slope equal to
the time constant k (or In 2/t1/2 where t1/2 is the half time for equilibrium). As shown in
Fig. 1 b, the increase in the rate of uptake in batrachotoxin solution is almost com-
pletely inhibited by 4 mM yohimbine.
The effect of yohimbine concentration on BTX-activated 22Na uptake is given in
Fig. 2. The experimental result is fit by a modified Michaelis-Menten equation
V = ax( K S+Y) (1)
(the solid curve) where Ko.5 is the apparent dissociation constant of the inhibitor
yohimbine, Y the yohimbine concentration, Vmax is the maximum velocity in the
absence of inhibitor, V the velocity measured at each yohimbine concentration. The
value of K0 sobtained from this dose-response relationship is 1.3 + 0.2 x 10-4 M.
Inhibition Pattern of Yohimbine
To determine whether yohimbine blocks activation by BTX in a competitive manner,
we have measured the 22Na uptake at different concentrations of BTX with various
fixed amounts of yohimbine. The data are presented as a Lineweaver-Burk plot
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FIGURE I (a) Inhibition of BTX-dependent 22Na uptake by yohimbine. The cells were first in-
cubated in preincubation media containing no BTX (o), I MAM BTX (a) or I ,M BTX plus 4 mM
yohimbine (m) for 30 min. The uptake was measured for the time indicated in the uptake medium
and the same amount of BTX and yohimbine as in the preincubation medium. (b) The same data
as in Fig. I a are plotted on semilogarithmic coordinates according to the solution of the first
order rate equation: In (QNa+ ]j0 /([Na ]," - [Na']')) = kt.
(Fig. 3). The experimental points fall on straight lines whose slopes vary with yohim-
bine concentration. Using an iterative least-square procedure, the experimental re-
sults were fit to the equation V = VmaxB/(K' 5 + B) where B is BTX concentration,
K6 5 is the "apparent" dissociation constant for BTX, and Vax and V have the same
definitions as before. Within the limit of experimental accuracy, Ko.5 changes markedly
with inhibitor concentration, whereas VJ'x is little affected. These results indicate
that yohimbine is a competitive inhibitor of BTX activation. Therefore, in Fig. 3, we
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FIGURE 2 Effect of yohimbine concentration on inhibition of BTX-dependent 22Na uptake.
Cells were preincubated with I AM BTX and the indicated concentration of yohimbine. The
uptake was then measured for 30 s in uptake medium consisting of I AM BTX and the indicated
yohimbine concentration. The Na' uptake in cell cultures treated with neither BTX nor yohim-
bine is subtracted. The ordinate "percent of activation" is the ratio of Na' uptake in cells
treated with I IMM BTX and indicated concentration of yohimbine vs. the uptake in cells treated
with only I MAM BTX.
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FIGURE 3 Inhibition pattern of BTX-dependent Na' uptake by yohimbine. The cells were pre-
incubated with the indicated concentration of BTX containing 0 (.), 10-4 M (A), 3 x 10-4 M
(o), 5 x 10-4 M (A), 7 x 10-4 M (-) yohimbine. The solid lines are the least square fits of equa-
tion Vmax * B/(K6.5 + B) with the assumption of a constant Vmax. The best fit values are Vmax =
130 nmol/min per mg K'5 = 0.4, 1.6, 4.0, 8.3, 15.6 AM at 0, 10- , 3 x 10-4, 5 x 10-4, 7 x
10-4 M yohimbine.
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assumed a constant V.,, and simultaneously fit all the data at different levels of yohim-
bine. The best fit values are Vnax = 130 nmol/min per mg, Ko5 = 0.4 uM at 0 yo-
himbine, K6.5 = 1.6 uM at IO-4 M yohimbine, K6.5 = 4.0 AM at 3 x 10-4 M, K65 =
8.3 MM at 5 x 10- M and KO.5 = 15.6 uM at 7 x 10-4 M yohimbine. Since yo-
himbine and batrachotoxin interact competitively, the concentration of yohimbine re-
quired for 50% inhibition of Na+ uptake in the presence of BTX is larger than the true
KD for yohimbine. Calculation of the KD for yohimbine from the data of Fig. 2 gives
a value of 4.1 x 10-5 M.
Veratridine also activates Na+ channels in neuroblastoma cells (Catterall and
Nirenberg, 1973; Catterall, 1975). Experiments similar to those reported above for
yohimbine and BTX show that yohimbine also markedly increases the value of K5.5
for veratridine and has little effect on Vmax. This result is expected since previous ex-
periments showed that veratridine and batrachotoxin act at a common receptor site in
activating Na+ channels (Catterall, 1975).
Rate of Yohimbine Action
The rate of yohimbine action was studied to further substantiate the conclusion that
yohimbine, veratridine, and batrachotoxin interact competitively. Cells were first
incubated with veratridine or batrachotoxin for 30 min and then were incubated fur-
ther for various times with yohimbine plus veratridine or batrachotoxin. Finally,
22Na+ uptake was measured. The inhibition of veratridine activation was complete
in 5 min, whereas the inhibition of batrachotoxin activation required more than 30 min
(Fig. 4). This result is inconsistent with a noncompetitive inhibition mechanism in
which the nature of the activator should have no effect on the rate of action of the
inhibitor. These results are consistent with a competitive inhibition mechanism since
the activator must dissociate from its receptor site before the inhibitor can bind. The
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FIGURE 4 Time-course of action of yohimbine. N-18 Cells were first preincubated in Na+-free
preincubation media containing 1 MM BTX for 30 mm (A), or 100mM veratridine (-) for 5 mm.
Cells were subsequently incubated in Na+-free preincubation media with 1 MM BTX plus 2 x
10- M yohimbine (A), or 100MM veratridine plus 2 x 10-4 M yohimbine (-) for the time shown.
Thus the abscissa is the time exposed to yohimbine. The rate of Na+ uptake was measured in
uptake media for 1 min.
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FIGURE 5 The reversal of inhibition by yohimbine. Cells were preincubated in preincubation
media containing 1 AM BTX plus 2 x l0-4 M yohimbine (A), or 100 AM veratridine plus 2 x
l0-4 yohimbine (o) for 30 min. After washing the media away, we again incubated the cells in pre-
incubation media with I AM BTX (A) or 100 AM veratridine (.) for the indicated times. The
uptakes were assayed in uptake media for I min.
rate of yohimbine inhibition of veratridine activation is similar to the rate of dissocia-
tion of veratridine (t1/2 < I min [Catterall, 1975]) and the rate of yohimbine inhibi-
tion of batrachotoxin activation is similar to the rate of dissociation of batrachotoxin
41/2 = 30 min [Catterall, 1975]). This is consistent with competitive inhibition if
yohimbine binding is relatively fast compared to activator binding.
Experiments in which the rate of recovery from yohimbine inhibition was studied
also support a competitive inhibition mechanism (Fig. 5). In these experiments, it is
expected from the competitive mechanism that the rates of recovery from yohimbine
inhibition will be similar to the rates at which veratridine and batrachotoxin bind to
their receptor site. Consistent with this, we find that the rate of recovery in the pres-
ence of veratridine is rapid, like the activation of Na+ channels by veratridine (t1/2 <
I min [Catterall, 1975]), whereas the rate of recovery in the presence of batrachotoxin
is slow, like the activation by batrachotoxin (t,/2 = 6 min [Catterall, 1975]). If vera-
tridine and batrachotoxin were able to bind to their site of action in the presence of
yohimbine, both rates would be rapid reflecting the rapid dissociation rate of yohim-
bine.' Thus both the rate of yohimbine inhibition and the rate of recovery from yo-
himbine inhibition are determined by the rates of association and dissociation of
veratridine and batrachotoxin. These results imply that veratridine and batrachotoxin
are excluded from their site of action by yohimbine and thus support a competitive
inhibition mechanism.
Inhibition of22Na Uptake by Yohimbine at Various Membrane Potential
The observations on yohimbine-treated squid axons indicated that the inhibition of
sodium current increases with the magnitude of a series of repetitive depolarizing
pulses. We have studied the effect of yohimbine at different membrane potentials.
From both microelectrode impalement of large neuroblastoma cells and the uptake of
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FIGURE 6 (a) The effect of membrane potential on inhibition by yohimbine. Cells were prein-
cubated in media containing I ,uM BTX concentration of yohimbine and 135 mM K+ (*A) or
5.0 mM K+ (oA), and choline chloride such that [K+] + [choline+] = 135 mM. The rate of up-
takes was then measured in assayed media with 135 mM K+ (-A), or 5 mM K+ (eo) and ap-
propriate amount of choline chloride for 30 s. (b) The 22Na uptake values measured in different
media were normalized with respect to their maximum level of stimulation and fitted by equation
V= Vmax(l- Y/(Ko.5+ Y))with Vmax = 112.8 nmol/min per mgandK= 1.3x 10-4 M.
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thiocyanate, the membrane potential was found to be -41 mV at 5.4 mM extracellular
potassium, 0 mV at 135 mM potassium, (Catterall et al., 1976). By changing KCI
concentration in the preincubation and assay medium, we are able, therefore, to vary
the membrane potential in the neuroblastoma cells.
The effect of yohimbine concentration on BTX-dependent uptake at K + concen-
trations of 135 and 5.4 mM, is illustrated in Fig. 6a. As shown here, the apparent dis-
sociation constant K0.5 does not change as the membrane potential changes from
-40 to 0 mV. The lower rate of uptake in [K]o = 5 mM preincubation medium is due
to the loss of intracellular potassium during 30 min of preincubating the cells in a low
potassium environment. Thus the 22Na uptake measurement is carried out at some-
what lower membrane potential as compared to those of the cells preincubated in a
high K + medium. When the 22Na uptake is measured in low and high potassium up-
take medium, an identical value of K0.5 is obtained. The low rate of uptake in high K +
uptake medium is again a result of reduction of electrical driving force for inward
sodium movement during the uptake period. These 22Na uptake values measured in
different media when normalized with respect to their maximum levels of stimulation,
can be fitted by a modified Michaelis-Menten equation (Eq. 1) with a single apparent
K0.5 of 1.3 i 0.2 x 10-4 M (Fig. 6 b). Thus, despite the fact that a series of short
(5 ms) 40 mV depolarization pulses result in noticeable enhancement of sodium current
inhibition by yohimbine in squid, long-term depolarization does not alter the affinity
ofyohimbine for its binding site in neuroblastoma cells.
DISCUSSION
Batrachotoxin-activated sodium channels have different conductance, gating prop-
erties (Khodorov, 1977) and ion selectivity (Khodorov, 1977; Huang et al. 1978) than
do normal channels. In comparing our results to the results of voltage clamp experi-
ments on squid axon,' it is important to consider whether batrachotoxin acts on nor-
mal sodium channels. Several lines of evidence suggest that it does. (a) BTX-activated
and normal sodium channels are blocked by tetrodotoxin with a K, in the nanomolar
range (Catterall, 1975; Cuervo and Adelman, 1970). In denervated rat muscle and in
cultured rat muscle cells, action potentials are relatively resistant to tetrodotoxin. In
both of these preparations, high concentration of tetrodotoxin (K1 = 1 ,M) is also
required to inhibit the sodium permeability increase caused by veratridine and ba-
trachotoxin (Albuquerque and Warnick, 1972; Catterall, 1976). (b) In node of Ran-
vier, Khodorov (1977) has studied the time-course of the action of batrachotoxin.
Under the influence of batrachotoxin, the normal sodium current gradually decreases
and a new component of sodium current of different kinetics and voltage-dependency
gradually develops. (c) Variant neuroblastoma cells which specifically lack the de-
polarizing phase of action potential (Minna et al., 1971) do not respond to treatment
with veratridine or batrachotoxin (Catterall and Nirenberg, 1973; Catterall, 1975).
These results show that normal sodium channels must be present in order for ba-
trachotoxin or veratridine to increase sodium permeability. These three lines of evi-
dence, taken together, support the conclusion that batrachotoxin or veratridine acti-
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vates normal sodium channels. In the discussion to follow, we assume that this is
correct.
Batrachotoxin is used to activate the sodium channels in most parts of our studies
since batrachotoxin, at 1/200 the concentration of veratridine, yields three to four
times larger maximum stimulation of sodium transport activity than veratridine, and
thus gives more accurate measurement ofNaI uptake rates.
Our results show that yohimbine reduces batrachotoxin-induced permeability to
sodium. The hyperbolic shapes of the dose-response curve and the reversibility of the
inhibition suggest that yohimbine binds to a single class of noninteracting sites with a
dissociation constant KD = 3-4 x 10-5 M. The rate of action for yohimbine is fast
and rate of reversal is also rapid (t1/2 < 1 min). Most experiments are done by using
high potassium (135 mM) preincubation medium and normal potassium (5 mM) up-
take medium. This prevents the loss of intracellular potassium during the preincuba-
tion period and insures an identical electrochemical driving force for sodium at differ-
ent yohimbine concentrations during the uptake measurements. The results given here
are, therefore, under the condition for the binding of yohimbine in depolarized cells.
As shown in Fig. 6, the membrane potential does not change the apparent dissociation
constant or the effect of yohimbine. Thus the affinity of yohimbine for its binding site
remains constant at different potentials. In a voltage clamp experiment, use-dependent
inhibition by yohimbine is observed during depolarizing pulsing.' During each pulse,
both the membrane potential and the number of open channels change, and it is diffi-
cult to establish which effect is the cause of the increased binding of yohimbine. In the
experiments reported here, the membrane potential is changed without changing the
number of channels, since the number of open channels depends only on the concen-
tration of batrachotoxin. As indicated above, the change of membrane potential does
not cause a change in the binding of yohimbine. It follows that membrane potential,
itself, is not the cause of use-dependent inhibition. The opening of channels, on the
other hand, is a likely cause of the increased inhibition by yohimbine during repeti-
tive pulsing.
The flux experiments shown here are always done in the presence of two drugs, ba-
trachotoxin and yohimbine. This is dictated by the fact that in the absence of an acti-
vator such as batrachotoxin, most (>99%) of the Na+ channels are closed. The differ-
ence between the uptake by cells with and without yohimbine treatment would,
therefore, be experimentally undetectable. By measuring batrachotoxin-dependent
22Na uptake in the presence of yohimbine, we are able to study the effect of yohimbine
on Na+ channels in neuroblastoma cells. On the other hand, in the electrophysiologi-
cal studies of squid axon, the yohimbine effect is studied as a reduction in the Na+
current flow during transient depolarization of the axon. Thus, in the flux experiments,
the interaction of two drugs is studied under steady-state conditions whereas, in the
voltage clamp experiments, the action of a single drug is studied under transient con-
ditions.2
2See note I above.
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Two mechanisms can conceivably account for the reduction of sodium current by
an inhibitor. The inhibitor molecule may enter into the mouth of the pore and bind
there. The transport of sodium ions is then impeded by the presence of this large
molecule in the channel mouth. On the other hand, the inhibitor may bind to a specific
site on the gating molecules which may be embedded in the hydrophobic region of the
membrane and spatially removed from the pore. The binding changes the free energy
for the open and closed states of the gating molecules, and thus affects the sodium
permeability.
It has been suggested that tetrodotoxin and saxitoxin block the sodium channels by
an occlusion mechanism (Henderson et al., 1974; Hille, 1975). Both of these molecules
contain a guanidinium group which is small enough to enter the channels. In contrast,
yohimbine is a large hydrophobic molecule and is unlikely to enter the sodium chan-
nels. It is probable, therefore, that yohimbine inhibits Na+ channels by a mechanism
that does not involve binding within the ion channel.
Both our kinetic and equilibrium experiments show that yohimbine is a competi-
tive inhibitor of the action of batrachotoxin. These results support the conclusion that
yohimbine acts by affecting channel gating processes rather than by occluding the
channel. For BTX-activated channels, drugs which bind within the lumen of the ion
channel and occlude it must reduce the maximum velocity of ion movement and,
therefore, are expected to be noncompetitive inhibitors of the action of batrachotoxin.
Tetrodotoxin, which has been postulated to occlude the Na+ channel (Henderson et
al., 1974; Hille, 1975) is a noncompetitive inhibitor of the action of veratridine and
batrachotoxin (Catterall, 1975). In contrast, we find that yohimbine is a competitive
inhibitor of the action of batrachotoxin and has no effect on the maximum velocity of
ion movement at saturation concentration of batrachotoxin. These results clearly
distinguish between the sites of action of tetrodotoxin and yohimbine, and indicate
that yohimbine does not block the Na+ channel by occlusion.
The principle alternative mechanism by which yohimbine can inhibit Na+ current
is to reduce the activation of Na+ channels by altering the gating processes. The com-
petitive inhibition patterns we observe might arise in two ways that are consistent with
this mechanism. First, yohimbine may bind at the batrachotoxin receptor site and
physically prevent binding of batrachotoxin. Since batrachotoxin alters gating pro-
cesses (Khodorov, 1977) and activates Na + channels, its receptor site must be located
on regions of the Na+ channel involved in gating processes. Interaction of yohimbine
with this site would be consistent with its electrophysiologic effects' and the competi-
tive interaction demonstrated here. The observed use-dependence of yohimbine in-
hibition suggests that it binds more rapidly to open Na+ channels than to closed Na+
channels.' An analogous use-dependent enhancement of batrachotoxin action has
been described (Khodorov, 1977). These observations are consistent with the view
that yohimbine and batrachotoxin interact with a common site on the gating structures
of Na+ channels.
A second plausible mechanism which also will yield competitive inhibition patterns
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is that yohimbine may bind at a site separate from the batrachotoxin receptor site, and
reduce the affinity for batrachotoxin.
There are striking similarities in the properties and mechanism of action of drugs
like batrachotoxin which activates Na+ channels, and yohimbine which blocks activa-
tion of Na+ channels. Both drugs are positively charged and lipid soluble. The action
of both classes of drugs is enhanced by repetitive activation of Na+ channels. It seems
possible that these two seemingly opposite types of drugs may act via a common
mechanism. A unified model for the action of such drugs based on the models pre-
sented by Catterall (1975, 1977) and Lipicky et al.1 is currently under study.
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